Loading...
Carmat SA
CKMTF•PNK
Healthcare
Medical - Devices
$12.75
$-13.25(-50.96%)

The company's financials show resilient growth, with revenue advancing from $553000.00 in Q2 2023 to $3.30M in Q2 2024. Gross profit remained healthy with margins at -642% in Q2 2024 compared to -4581% in Q2 2023. Operating income hit -$25.40M last quarter, sustaining a consistent -770% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$52.40M. Net income rose to -$26.20M, while earnings per share reached -$1.15. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan